Cargando…

A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome

Objective: To propose a novel scale for the assessment of stroke severity at symptom onset and to investigate whether it is associated with ultra-early neurological deterioration (UND) and functional outcomes. Methods: The Chongqing Stroke Scale (CQSS) was constructed based on key aspects of history...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi, Deng, Lan, Huang, Cheng, Zhang, Wen-Yu, Zou, Ning, Cao, Du, Wei, Xiao, Qin, Xin-Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862557/
https://www.ncbi.nlm.nih.gov/pubmed/33551962
http://dx.doi.org/10.3389/fneur.2020.602839
_version_ 1783647310912159744
author Li, Qi
Deng, Lan
Huang, Cheng
Zhang, Wen-Yu
Zou, Ning
Cao, Du
Wei, Xiao
Qin, Xin-Yue
author_facet Li, Qi
Deng, Lan
Huang, Cheng
Zhang, Wen-Yu
Zou, Ning
Cao, Du
Wei, Xiao
Qin, Xin-Yue
author_sort Li, Qi
collection PubMed
description Objective: To propose a novel scale for the assessment of stroke severity at symptom onset and to investigate whether it is associated with ultra-early neurological deterioration (UND) and functional outcomes. Methods: The Chongqing Stroke Scale (CQSS) was constructed based on key aspects of history, emphasizing language, motor function, and level of consciousness to yield a total 0–11 scale. The diagnostic performance of the CQSS was assessed in 215 ischemic stroke patients between June 2017 and October 2017 in a tertiary hospital. Patients were included if they presented within 24 h after onset of symptoms and they or their witness can recall the scenario at symptom onset. UND was defined as an increase ≥2 points on the CQSS between symptom onset and admission. Functional outcomes were assessed using the 3-month modified Rankin scale. The correlation between the CQSS score and baseline National Institutes of Health Stroke Scale (NIHSS) score was assessed. The sensitivity, specificity, and positive and negative predictive values of CQSS for the outcomes were calculated. Logistic regression was used to test the association between the CQSS score and functional outcomes. Results: A total of 215 patients with available CQSS scores were included. Baseline CQSS scores at symptom onset were correlated with the admission NIHSS score (r = 0.56, p < 0.001) and functional outcome at 3 months (r = 0.47, p < 0.001). Baseline CQSS ≥ 6 was an independent predictor of functional outcome at 3 months (odds ratio, 12.61; 95% confidence interval 5.68–27.97, p < 0.001). UND was observed in 20 (9.30%) patients. The 90-day mortality was significantly higher in patients with UND than those without UND (25.0 vs. 8.2%, p < 0.001). After adjusting for age, admission systolic blood pressure, hypertension, and diabetes, UND independently predicted poor functional outcome in the multivariate logistic regression model (odds ratio, 9.69; 95% confidence interval 3.19–29.45, p < 0.001). Conclusions: The newly developed CQSS is a simple and easy-to-perform scale that allows a quantitative evaluation of the stroke severity at symptom onset and an assessment of UND before hospital admission. It is associated with NIHSS and predicts functional outcome in patients with acute ischemic stroke.
format Online
Article
Text
id pubmed-7862557
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78625572021-02-06 A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome Li, Qi Deng, Lan Huang, Cheng Zhang, Wen-Yu Zou, Ning Cao, Du Wei, Xiao Qin, Xin-Yue Front Neurol Neurology Objective: To propose a novel scale for the assessment of stroke severity at symptom onset and to investigate whether it is associated with ultra-early neurological deterioration (UND) and functional outcomes. Methods: The Chongqing Stroke Scale (CQSS) was constructed based on key aspects of history, emphasizing language, motor function, and level of consciousness to yield a total 0–11 scale. The diagnostic performance of the CQSS was assessed in 215 ischemic stroke patients between June 2017 and October 2017 in a tertiary hospital. Patients were included if they presented within 24 h after onset of symptoms and they or their witness can recall the scenario at symptom onset. UND was defined as an increase ≥2 points on the CQSS between symptom onset and admission. Functional outcomes were assessed using the 3-month modified Rankin scale. The correlation between the CQSS score and baseline National Institutes of Health Stroke Scale (NIHSS) score was assessed. The sensitivity, specificity, and positive and negative predictive values of CQSS for the outcomes were calculated. Logistic regression was used to test the association between the CQSS score and functional outcomes. Results: A total of 215 patients with available CQSS scores were included. Baseline CQSS scores at symptom onset were correlated with the admission NIHSS score (r = 0.56, p < 0.001) and functional outcome at 3 months (r = 0.47, p < 0.001). Baseline CQSS ≥ 6 was an independent predictor of functional outcome at 3 months (odds ratio, 12.61; 95% confidence interval 5.68–27.97, p < 0.001). UND was observed in 20 (9.30%) patients. The 90-day mortality was significantly higher in patients with UND than those without UND (25.0 vs. 8.2%, p < 0.001). After adjusting for age, admission systolic blood pressure, hypertension, and diabetes, UND independently predicted poor functional outcome in the multivariate logistic regression model (odds ratio, 9.69; 95% confidence interval 3.19–29.45, p < 0.001). Conclusions: The newly developed CQSS is a simple and easy-to-perform scale that allows a quantitative evaluation of the stroke severity at symptom onset and an assessment of UND before hospital admission. It is associated with NIHSS and predicts functional outcome in patients with acute ischemic stroke. Frontiers Media S.A. 2021-01-22 /pmc/articles/PMC7862557/ /pubmed/33551962 http://dx.doi.org/10.3389/fneur.2020.602839 Text en Copyright © 2021 Li, Deng, Huang, Zhang, Zou, Cao, Wei and Qin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Li, Qi
Deng, Lan
Huang, Cheng
Zhang, Wen-Yu
Zou, Ning
Cao, Du
Wei, Xiao
Qin, Xin-Yue
A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome
title A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome
title_full A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome
title_fullStr A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome
title_full_unstemmed A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome
title_short A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome
title_sort novel scale for assessment of stroke severity at symptom onset: correlation with neurological deterioration and outcome
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862557/
https://www.ncbi.nlm.nih.gov/pubmed/33551962
http://dx.doi.org/10.3389/fneur.2020.602839
work_keys_str_mv AT liqi anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT denglan anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT huangcheng anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT zhangwenyu anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT zouning anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT caodu anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT weixiao anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT qinxinyue anovelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT liqi novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT denglan novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT huangcheng novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT zhangwenyu novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT zouning novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT caodu novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT weixiao novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome
AT qinxinyue novelscaleforassessmentofstrokeseverityatsymptomonsetcorrelationwithneurologicaldeteriorationandoutcome